GlassScriptPhysician profile
Marwan M Bahu
NPI 1114920618
$38,014.09
in general payments reported to CMS, 2019-2025
25 companies · $3,026 in 2025
The $3,026 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,678 · 2020: $5,378 · 2021: $4,369 · 2022: $3,852 · 2023: $11K · 2024: $8,863 · 2025: $3,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,904 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,805 · Travel and Lodging: $3,243 · Consulting Fee: $2,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,903.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,805.00 |
| Travel and Lodging | $3,243.32 |
| Consulting Fee | $2,785.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $11,473.04 | 2019-2025 | Carto 3, Thermocool Sf, Nuvision Ice Catheter |
| Boston Scientific Corporation | $6,165.68 | 2019-2025 | Watchman Access System, Watchman Flx, General - Therapies |
| Cvrx, INC. | $6,067.43 | 2019-2025 | Barostim Neo System |
| Ge Healthcare | $4,590.00 | 2023-2024 | |
| Abbott Laboratories | $4,085.36 | 2019-2025 | Aveir, Mitraclip, Gallant |
| Medtronic, INC. | $2,051.36 | 2021-2025 | Cobalt Dr Mri Surescan, Micra, Aurora Ev-Icd Mri Surescan |
| Volta Medical INC | $1,381.55 | 2023-2024 | Vx1 |
| Medtronic Vascular, INC. | $807.74 | 2019-2020 | |
| Atricure, INC. | $346.87 | 2022 | |
| Biotronik INC. | $326.24 | 2020-2024 | |
| Abiomed | $260.97 | 2021-2022 | |
| Cardiva Medical, INC. | $132.63 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Penumbra, INC. | $129.97 | 2019 | |
| Bardy Diagnostics, INC. | $30.00 | 2022 | |
| Gilead Sciences, INC. | $25.13 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $24.20 | 2019 | |
| Edwards Lifesciences Corporation | $23.66 | 2025 | Pascal |
| Novartis Pharmaceuticals Corporation | $22.38 | 2024 | |
| Philips North America LLC | $20.45 | 2021 | |
| Novo Nordisk INC | $19.19 | 2025 | Wegovy |
| Elutia, INC. | $12.06 | 2019 | |
| Altathera Pharmaceuticals LLC | $11.69 | 2023 | Sotalol Hydrochloride |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.49 | 2025 | Lifevest |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marwan Bahu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.